Kyverna Therapeutics Files 8-K with Exhibits
Ticker: KYTX · Form: 8-K · Filed: Apr 22, 2026 · CIK: 0001994702
Sentiment: neutral
Topics: disclosure, exhibits
TL;DR
Kyverna Therapeutics dropped an 8-K on 4/22/26 with exhibits - check EX-99.1 for deets.
AI Summary
Kyverna Therapeutics, Inc. filed an 8-K on April 22, 2026, primarily for Regulation FD Disclosure and Financial Statements/Exhibits. The filing includes an exhibit (EX-99.1) which contains various graphic files, suggesting it may contain visual data or presentations related to the company's operations or financial status.
Why It Matters
This filing provides updated information and exhibits for Kyverna Therapeutics, Inc., which could contain material details for investors and interested parties regarding the company's current status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosure and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Kyverna Therapeutics, Inc. (company) — Filer of the 8-K
- 0001994702 (company) — CIK number for Kyverna Therapeutics, Inc.
- 0001193125-26-168287 (other) — SEC Accession Number for the filing
- 2026-04-22 (date) — Filing Date and Period of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing, filed on April 22, 2026, is for Regulation FD Disclosure (Item 7.01) and to provide Financial Statements and Exhibits (Item 9.01).
What is the accession number for this SEC filing?
The SEC accession number for this filing by Kyverna Therapeutics, Inc. is 0001193125-26-168287.
What type of document is EX-99.1 mentioned in the filing?
EX-99.1 is listed as an exhibit to the 8-K filing and is in an iXBRL format, with associated graphic files.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 22, 2026, at 07:00:13.
What are the main items disclosed in this 8-K filing?
The main items disclosed in this 8-K filing are Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2026 regarding Kyverna Therapeutics, Inc. (KYTX).